↓ Skip to main content

BMJ

EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome

Overview of attention for article published in Annals of the Rheumatic Diseases, February 2022
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news
7 news outlets
blogs
1 blog
twitter
212 X users
facebook
2 Facebook pages

Citations

dimensions_citation
147 Dimensions

Readers on

mendeley
181 Mendeley
Title
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome
Published in
Annals of the Rheumatic Diseases, February 2022
DOI 10.1136/annrheumdis-2021-221733
Pubmed ID
Authors

George C Drosos, Daisy Vedder, Eline Houben, Laura Boekel, Fabiola Atzeni, Sara Badreh, Dimitrios T Boumpas, Nina Brodin, Ian N Bruce, Miguel Ángel González-Gay, Søren Jacobsen, György Kerekes, Francesca Marchiori, Chetan Mukhtyar, Manuel Ramos-Casals, Naveed Sattar, Karen Schreiber, Savino Sciascia, Elisabet Svenungsson, Zoltan Szekanecz, Anne-Kathrin Tausche, Alan Tyndall, Vokko van Halm, Alexandre Voskuyl, Gary J Macfarlane, Michael M Ward, Michael T Nurmohamed, Maria G Tektonidou

X Demographics

X Demographics

The data shown below were collected from the profiles of 212 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 181 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 181 100%

Demographic breakdown

Readers by professional status Count As %
Other 21 12%
Researcher 16 9%
Student > Ph. D. Student 15 8%
Student > Bachelor 12 7%
Professor 8 4%
Other 33 18%
Unknown 76 42%
Readers by discipline Count As %
Medicine and Dentistry 68 38%
Biochemistry, Genetics and Molecular Biology 9 5%
Immunology and Microbiology 6 3%
Nursing and Health Professions 5 3%
Sports and Recreations 2 1%
Other 11 6%
Unknown 80 44%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 189. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 February 2024.
All research outputs
#218,213
of 26,004,690 outputs
Outputs from Annals of the Rheumatic Diseases
#80
of 7,857 outputs
Outputs of similar age
#6,731
of 529,224 outputs
Outputs of similar age from Annals of the Rheumatic Diseases
#2
of 69 outputs
Altmetric has tracked 26,004,690 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 7,857 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 14.3. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,224 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 69 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.